Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis

Abstract

Journal Article Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritis Get access Atsushi Komatsuda, Atsushi Komatsuda Third Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan Correspondence to: Atsushi Komatsuda, Third Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan e-mail: komatsud@med.akita-u.ac.jp Search for other works by this author on: Oxford Academic Google Scholar Hideki Wakui, Hideki Wakui Third Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan Search for other works by this author on: Oxford Academic Google Scholar Takashi Nimura, Takashi Nimura Department of Internal Medicine, Senboku General Hospital, Daisen, Japan Search for other works by this author on: Oxford Academic Google Scholar Ken-ichi Sawada Ken-ichi Sawada Third Department of Internal Medicine, Akita University School of Medicine, 1-1-1 Hondo, Akita 010-8543, Japan Search for other works by this author on: Oxford Academic Google Scholar Modern Rheumatology, Volume 18, Issue 3, 1 June 2008, Pages 315–318, https://doi.org/10.3109/s10165-008-0053-0 Published: 01 June 2008 Article history Received: 07 December 2007 Accepted: 01 February 2008 Published: 01 June 2008